AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
5.24
+0.03 (0.58%)
At close: Jun 18, 2025, 4:00 PM
5.25
+0.01 (0.19%)
After-hours: Jun 18, 2025, 4:04 PM EDT
AVITA Medical Stock Forecast
Stock Price Forecast
The 4 analysts that cover AVITA Medical stock have a consensus rating of "Strong Buy" and an average price target of $16.5, which forecasts a 214.89% increase in the stock price over the next year. The lowest target is $12 and the highest is $21.
Price Target: $16.5 (+214.89%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AVITA Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $19 | Strong Buy | Maintains | $19 | +262.60% | Jun 10, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $19 | Strong Buy | Maintains | $19 | +262.60% | Jun 6, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $22 | Strong Buy | Maintains | $22 | +319.85% | Apr 10, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $22 | Strong Buy | Maintains | $22 | +319.85% | Apr 4, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $22 | Strong Buy | Maintains | $22 | +319.85% | Mar 18, 2025 |
Financial Forecast
Revenue This Year
101.06M
from 64.25M
Increased by 57.29%
Revenue Next Year
129.43M
from 101.06M
Increased by 28.07%
EPS This Year
-0.68
from -2.39
EPS Next Year
-0.18
from -0.68
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 110.4M | 147.0M | 312.9M | ||
| Avg | 101.1M | 129.4M | 183.8M | ||
| Low | 90.4M | 108.6M | 127.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 71.7% | 45.5% | 141.7% | ||
| Avg | 57.3% | 28.1% | 42.0% | ||
| Low | 40.7% | 7.5% | -1.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.18 | -0.04 | 5.46 | ||
| Avg | -0.68 | -0.18 | 1.70 | ||
| Low | -0.99 | -0.30 | -0.05 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.